학술논문
Pharmacokinetic and Pharmacodynamic Properties and Tolerability of Single- and multiple-dose Once-daily Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus
Document Type
Article
Author
Source
In: Clinical Therapeutics . (Clinical Therapeutics, 21 July 2015, 37(7):1493-1502)
Subject
Language
English
ISSN
1879114X
01492918
01492918